Skip to main content

Advertisement

SpringerLink
Log in

Impact of Percutaneous Transluminal Angioplasty for Treatment of Cerebral Vasospasm on Subarachnoid Hemorrhage Patient Outcomes

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Percutaneous transluminal angioplasty (PTA) has been introduced for treatment of symptomatic cerebral vasospasm in patients with subarachnoid hemorrhage (SAH). While angiographic improvement is consistently reported, clinical improvement following the procedure varies, and limited data is available regarding overall impact on outcome.

Methods

The authors performed a retrospective analysis of all hospital admissions with aneurysmal SAH over a 6 year period. The length of stay, discharge outcomes (measured by modified Rankin scale [mRS] at discharge), and 1-year mortality among patients with SAH before (4 year period) and after (2 year period) institution of PTA for cerebral vasospasm were compared. Embolization for intracranial aneurysm was used as a therapeutic option throughout the study duration. The effect of institution of PTA for vasospasm after adjusting for age, clinical severity, and use of aneurysm embolization on both discharge outcomes and 1-year mortality in multivariate analysis was evaluated.

Results

A total of 146 patients with aneurysmal SAH were admitted during the study duration. There was no difference between the 89 patients admitted in pre-angioplasty period and 57 patients admitted in post-angioplasty period in regards to age, medical co-morbidities, and admission clinical severity of patients (measured by Hunt and Hess grade and Glasgow coma scale). A total of 18 (32%) patients underwent PTA with or without intra-arterial vasodilator treatment in the second period of the study. There was a non significant decrease in rates of severe disability and death (mRS 5–6) at discharge (45 vs. 33%, P = 0.09) and 1-year mortality (32 vs. 22%, P = 0.26) after introduction of PTA for cerebral vasospasm after adjusting for potential confounders. There was no significant difference between the two time periods in regards to length of stay.

Conclusion

A non significant trend was noted with reduced rate of severe disability and mortality at discharge and 1-year mortality after the introduction of PTA for cerebral vasospasm associated with SAH without increasing the length of hospital stay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Truelsen T, Bonita R, Duncan J, et al. Changes in subarachnoid hemorrhage mortality, incidence, and case fatality in New Zealand between 1981–1983 and 1991–1993. Stroke. 1998;29(11):2298–303.

    Article  PubMed  CAS  Google Scholar 

  2. Ayala C, Greenlund KJ, Croft JB, et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995–1998. Am J Epidemiol. 2001;154(11):1057–63.

    Article  PubMed  CAS  Google Scholar 

  3. Adams HP Jr, Putman SF, Kassell NF, et al. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol. 1984;41(10):1033–5.

    PubMed  Google Scholar 

  4. Biller J, Godersky JC, Adams HP Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke. 1988;19(10):1300–5.

    Article  PubMed  CAS  Google Scholar 

  5. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery. 2001;48(2):249–61. discussion 261–242.

    PubMed  CAS  Google Scholar 

  6. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien). 1984;70(1–2):65–79.

    Article  CAS  Google Scholar 

  7. Newell DW, Eskridge JM, Mayberg MR, et al. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg. 1989;71(5 Pt 1):654–60.

    PubMed  CAS  Google Scholar 

  8. Linskey ME, Horton JA, Rao GR, et al. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Case report. J Neurosurg. 1991;74(6):985–90.

    Article  PubMed  CAS  Google Scholar 

  9. Takis C, Kwan ES, Pessin MS, et al. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol. 1997;18(9):1661–8.

    PubMed  CAS  Google Scholar 

  10. AJNR. Mechanical and pharmacologic treatment of vasospasm. Am J Neuroradiol. 2001;22(8 Suppl):S26–7.

    Google Scholar 

  11. Barnwell SL, Higashida RT, Halbach VV, et al. Transluminal angioplasty of intracerebral vessels for cerebral arterial spasm: reversal of neurological deficits after delayed treatment. Neurosurgery. 1989;25(3):424–9.

    Article  PubMed  CAS  Google Scholar 

  12. Bejjani GK, Bank WO, Olan WJ, et al. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1998;42(5):979–86. discussion 986–977.

    Article  PubMed  CAS  Google Scholar 

  13. Eskridge JM, Newell DW, Pendleton GA. Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am. 1990;1(2):387–99.

    PubMed  CAS  Google Scholar 

  14. Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;92(2):284–90.

    Article  PubMed  CAS  Google Scholar 

  15. http://notes.bluecrossmn.com/web/medpolman.nsf/8178b1c14b1e9b6b8525624f0062fe9f/eb9611de760de2128625717100690182?OpenDocument&Highlight=0,percutaneous. Accessed 12 Sept 2009.

  16. http://www.aetna.com/cpb/medical/data/200_299/0276.html. Accessed 12 Sept 2009.

  17. Khatri R, Tariq N, Vazquez G, et al. Outcomes after nontraumatic subarachnoid hemorrhage at hospitals offering angioplasty for cerebral vasospasm: a National level analysis in the United States. Neurocrit Care. 2010. doi:10.1007/s12028-010-9423-5.

  18. Qureshi AI, Janardhan V, Memon MZ, et al. Initial experience in establishing an academic neuroendovascular service: program building, procedural types, and outcomes. J Neuroimaging. 2009;19(1):72–9.

    Article  PubMed  Google Scholar 

  19. Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100(1–2):12–24.

    Article  CAS  Google Scholar 

  20. Harrigan MR, Magnano CR, Guterman LR, et al. Computed tomographic perfusion in the management of aneurysmal subarachnoid hemorrhage: new application of an existent technique. Neurosurgery. 2005;56(2):304–17. discussion 304–17.

    Article  PubMed  Google Scholar 

  21. Moftakhar R, Rowley HA, Turk A, et al. Utility of computed tomography perfusion in detection of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurosurg Focus. 2006;21(3):E6.

    Article  PubMed  Google Scholar 

  22. Shah QA, Memon MZ, Suri MF, et al. Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):190–8.

    Article  PubMed  CAS  Google Scholar 

  23. Tejada JG, Taylor RA, Ugurel MS, et al. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR. 2007;28(5):844–8.

    PubMed  CAS  Google Scholar 

  24. Badjatia N, Topcuoglu MA, Pryor JC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR. 2004;25(5):819–26.

    PubMed  Google Scholar 

  25. Feng L, Fitzsimmons BF, Young WL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR. 2002;23(8):1284–90.

    PubMed  Google Scholar 

  26. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke. 2009;40(3):994–1025.

    Article  PubMed  Google Scholar 

  27. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308(11):619–24.

    Article  PubMed  CAS  Google Scholar 

  28. Lanzino G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg. 1999;90(6):1018–24.

    Article  PubMed  CAS  Google Scholar 

  29. Lanzino G, Kassell NF, Dorsch NW, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg. 1999;90(6):1011–7.

    Article  PubMed  CAS  Google Scholar 

  30. Zwienenberg-Lee M, Hartman J, Rudisill N, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39(6):1759–65.

    Article  PubMed  Google Scholar 

  31. Leng LZ, Fink ME, Iadecola C. Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. Arch Neurol. 2011;68(1):31–6.

    Article  PubMed  Google Scholar 

  32. Johnston SC. Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke. 2000;31(1):111–7.

    Article  PubMed  CAS  Google Scholar 

  33. Bardach NS, Zhao S, Gress DR, et al. Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke. 2002;33(7):1851–6.

    Article  PubMed  Google Scholar 

  34. Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke research. Stroke. 2002;33(10):2465–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zeenat Qureshi Stroke Research Center, Departments of Neurology and Neurosurgery, University of Minnesota, Minneapolis, MN, USA

    Rakesh Khatri, Muhammad Zeeshan Memon, Haralabos Zacharatos, Ather M. Taqui, Mushtaq H. Qureshi, Gabriela Vazquez, M. Fareed K. Suri, Gustavo J. Rodriguez, Ramachandra P. Tummala, Mustapha A. Ezzeddine & Adnan I. Qureshi

Authors
  1. Rakesh Khatri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Muhammad Zeeshan Memon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haralabos Zacharatos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ather M. Taqui
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mushtaq H. Qureshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gabriela Vazquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Fareed K. Suri
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gustavo J. Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ramachandra P. Tummala
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mustapha A. Ezzeddine
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Adnan I. Qureshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rakesh Khatri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khatri, R., Memon, M.Z., Zacharatos, H. et al. Impact of Percutaneous Transluminal Angioplasty for Treatment of Cerebral Vasospasm on Subarachnoid Hemorrhage Patient Outcomes. Neurocrit Care 15, 28–33 (2011). https://doi.org/10.1007/s12028-010-9499-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-010-9499-y

Keywords

Search

Navigation